Amlodipine in the Treatment of Raynaudʼs Phenomenon

of findings for the main comparison. Calcium channel blockers for primary Raynauds's phenomenon Calcium channel blockers for primary Raynauds's phenomenon Patient or population: primary Raynaud's phenomenon Setting: hospital and hospital outpatient clinics Intervention: calcium channel blockers Comparison: placebo Anticipated absolute effects * (95% CI) Outcomes Risk with placebo Risk with Calcium channel blockers Relative effect (95% CI) CI: Confidence interval; RR: Risk ratio; OR: Odds ratio; GRADE Working Group grades of evidence High quality: We are very confident that the true effect lies close to that of the estimate of the effect Moderate quality: We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different Low quality: Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect Cochrane Library Trusted evidence. Informed decisions. Better health.

show abstract

Amlodipine in the Treatment of Raynaudʼs Phenomenon

Cited by 5 publications

References 20 publications

Calcium channel blockers for primary and secondary Raynaud's phenomenon

Calcium channel blockers for primary and secondary Raynaud's phenomenon

Calcium channel blockers for primary Raynaud's phenomenon

Calcium channel blockers for primary Raynaud's phenomenon

Contact Info

Product

Resources

About